SCHEMBL7354310

SCHEMBL7354310

O=C(O)CC(Cc1ccccc1)C(=O)OCc1ccccc1

nearest known ligand 0.66

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CPA3 P15088 3/20 0.66
▸ CPA1 P15085 2/20 0.66
▸ CPB1 P15086 1/20 0.66
▸ CPB2 Q96IY4 1/20 0.66
▸ CYP1A2 P05177 1/20 0.53
▸ LTA4H P09960 2/20 0.51
▸ ALDH1A1 P00352 3/20 0.50
▸ MMP2 P08253 1/20 0.50
▸ MMP9 P14780 1/20 0.50
▸ MMP12 P39900 1/20 0.50
▸ SLC15A1 P46059 1/20 0.50
▸ MAPK1 P28482 1/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ SLC6A2 P23975 1/20 0.49
▸ SLC6A3 Q01959 1/20 0.49
▸ KMT2A Q03164 1/20 0.49
▸ TDP1 Q9NUW8 1/20 0.49
▸ CTRB1 P17538 2/20 0.48
▸ FOLH1 Q04609 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8399603 1.00 CPA3 (0.66) CPA3CPA1CPB1CPB2CYP1A2
SCHEMBL7289839 1.00 CPA3 (0.66) CPA3CPA1CPB1CPB2CYP1A2
SCHEMBL3701204 0.92 CPA1 (0.57) CPA3CPA1CPB1CPB2CYP1A2
SCHEMBL2571746 0.91 CPA1 (0.56) CPA3CPA1CPB1CPB2ALDH1A1
SCHEMBL7346272 0.91 CPA1 (0.55) CPA3CPA1CPB1CPB2CYP1A2
SCHEMBL7346268 0.91 CPA1 (0.55) CPA3CPA1CPB1CPB2CYP1A2
SCHEMBL21811160 0.87 CYP1A2 (0.59) CPA3CPA1CPB1CPB2CYP1A2
SCHEMBL7320025 0.87 ALDH1A1 (0.56) CPA3CPA1CPB1CPB2CYP1A2
SCHEMBL7320029 0.87 ALDH1A1 (0.56) CPA3CPA1CPB1CPB2CYP1A2
SCHEMBL28639320 0.86 CPA1 (0.51) CPA3CPA1CPB1CPB2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5869518-A USEFUL IN THE TREATMENT OF OBESITY AND HYPERGLYCEMIA SYNTHELABO (FR) 1999-02-09 — — US disclosed
US-5712417-A Inhibitors of retroviral proteases ABBOTT LABORATORIES (US) 1998-01-27 — — US disclosed
EP-0507534-B1 Succinic acid compounds KISSEI PHARMACEUTICAL (JP) 1996-02-28 — — EP disclosed
US-5442044-A Hypotensive agents PFIZER INC. (US) 1995-08-15 — — US disclosed
EP-0661292-A1 Orally active renin inhibitors PFIZER INC. (US) 1995-07-05 — — EP disclosed
US-5202335-A Hypoglycemic, antidiabetic agents KISSEI PHARMACEUTICAL CO., LTD. (JP) 1993-04-13 — — US disclosed
EP-0507534-A1 Succinic acid compounds KISSEI PHARMACEUTICAL CO., LTD. (JP) 1992-10-07 — — EP disclosed
EP-0438233-A2 Orally active renin inhibitors PFIZER INC. (US) 1991-07-24 — — EP disclosed
Send feedback